Ved sammenligning med dolasetron var disse værdier 63% for Aloxi (119 patienter ud af 189) og 53% for dolasetron (101 patienter ud af 191).
When it was compared with dolasetron, these values were 63% for Aloxi (119 patients out of 189) and 53% for dolasetron (101 patients out of 191).